These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37884429)

  • 1. Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk.
    van Gerwen M; Colicino E; Guan H; Dolios G; Nadkarni GN; Vermeulen RCH; Wolff MS; Arora M; Genden EM; Petrick LM
    EBioMedicine; 2023 Nov; 97():104831. PubMed ID: 37884429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
    Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer: Systematic review and meta-analysis.
    van Gerwen M; Chung T; Monaghan M; Vermeulen R; Petrick L; Leung AM
    Toxicol Lett; 2024 Aug; 399():52-58. PubMed ID: 39047923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nested Case-Control Study of Serum Per- and Polyfluoroalkyl Substances and Testicular Germ Cell Tumors among U.S. Air Force Servicemen.
    Purdue MP; Rhee J; Denic-Roberts H; McGlynn KA; Byrne C; Sampson J; Botelho JC; Calafat AM; Rusiecki J
    Environ Health Perspect; 2023 Jul; 131(7):77007. PubMed ID: 37458713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per- and polyfluoroalkyl substances and the associated thyroid cancer risk: A case-control study in China.
    Li H; Yang M; Yang J; Seery S; Ma C; Liu Y; Zhang X; Li A; Guo H
    Chemosphere; 2023 Oct; 337():139411. PubMed ID: 37419160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk.
    Rhee J; Barry KH; Huang WY; Sampson JN; Hofmann JN; Silverman DT; Calafat AM; Botelho JC; Kato K; Purdue MP; Berndt SI
    Environ Res; 2023 Jul; 228():115718. PubMed ID: 36958379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Per- and polyfluoroalkyl substances (PFAS) and thyroid hormone measurements in dried blood spots and neonatal characteristics: a pilot study.
    Rosen Vollmar AK; Lin EZ; Nason SL; Santiago K; Johnson CH; Ma X; Godri Pollitt KJ; Deziel NC
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):737-747. PubMed ID: 37730931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing exposures to per- and polyfluoroalkyl substances in two populations of Great Lakes Basin fish consumers in Western New York State.
    Liu M; Nordstrom M; Forand S; Lewis-Michl E; Wattigney WA; Kannan K; Wang W; Irvin-Barnwell E; Hwang SA
    Int J Hyg Environ Health; 2022 Mar; 240():113902. PubMed ID: 34915281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.
    Dunder L; Lind PM; Salihovic S; Stubleski J; Kärrman A; Lind L
    Environ Res; 2022 Aug; 211():112903. PubMed ID: 35231461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
    Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
    Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME Study.
    Lebeaux RM; Doherty BT; Gallagher LG; Zoeller RT; Hoofnagle AN; Calafat AM; Karagas MR; Yolton K; Chen A; Lanphear BP; Braun JM; Romano ME
    Environ Res; 2020 Jun; 185():109395. PubMed ID: 32222633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort.
    Goodrich JA; Walker D; Lin X; Wang H; Lim T; McConnell R; Conti DV; Chatzi L; Setiawan VW
    JHEP Rep; 2022 Oct; 4(10):100550. PubMed ID: 36111068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort.
    Mitro SD; Sagiv SK; Fleisch AF; Jaacks LM; Williams PL; Rifas-Shiman SL; Calafat AM; Hivert MF; Oken E; James-Todd TM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3415-26. PubMed ID: 32620010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to Per- and polyfluoroalkyl substances and adiposity measures of children at 4 and 6 years: A prospective birth cohort in China.
    Sun S; Xie Z; Song X; Wen S; Yuan W; Miao M; Ji H; Liang H
    Ecotoxicol Environ Saf; 2024 Jan; 269():115751. PubMed ID: 38042132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.